Article
HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
29 Jun 2020
Abstract excerpt
Thus, it is important to develop new and improved INSTIs that are effective against all the known resistant mutants. This led us to test our best inhibitors, in parallel with DTG, BIC, and CAB, in a single-round infection assay against a panel of the new CAB-resistant mutants. Of the INSTIs we tested, BIC and our compound 4d had the broadest efficacy. Both were superior to DTG, as evidenced by the data obtained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
